There’s been a possible major breakthrough in the fight against Ebola after trials of new drugs suggested they could make the disease ‘preventable and treatable’.
British drugmaker GlaxoSmithKline is giving up its work on developing three potential vaccines against the deadly Ebola and Marburg viruses, despite an ongoing Ebola outbreak in Democratic Republic of Congo.
Uganda has started its largest-ever trial of a preventive Ebola vaccine, an official said on Monday, amid fears of a potential spillover of the deadly hemorrhagic fever from neighbouring Democratic Republic of Congo.
Congolese authorities were racing to contain an Ebola epidemic after a gold miner with a large family contaminated several people in the east’s main city of Goma before dying of the haemorrhagic fever, officials said.
The Ebola outbreak in the eastern Democratic Republic of Congo and its spread to the dense population centre of Goma, underscores a real risk of a spike in the disease, perhaps beyond the country’s borders.